Clinical trial
A Prospective Study of Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors
NCT01105182 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Guangzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Radiofrequency Ablation Combined With Chemotherapy for Pulmonary Tumors
- Lead sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2009
- Completion date
- June 30, 2011
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nsclc, pulmonary metastases